Probing Majorana neutrinos in rare K and D, D_s, B, B_c meson decays

We study lepton number violating decays of charged K, D, D_s, B and B_c mesons of the form M^+\to {M'}^-\ell^+\ell^+, induced by the existence of Majorana neutrinos. These processes provide information complementary to neutrinoless double nuclear beta decays, and are sensitive to neutrino masses and lepton mixing. We explore neutrino mass ranges m_N from below 1 eV to several hundred GeV. We find that in many cases the branching ratios are prohibitively small, however in the intermediate range m_\pi < m_N < m_{B_c}, in specific channels and for specific neutrino masses, the branching ratios can be at the reach of high luminosity experiments like those at the LHC-b and future Super flavor-factories, and can provide bounds on the lepton mixing parameters.Comment: 25 page

Late-time Phase transition and the Galactic halo as a Bose Liquid: (II) the Effect of Visible Matter

In the previous work, we investigated the rotation curves of galaxies assuming that the dark matter consists of ultra light boson appearing in $'$late time phase transition' theory. Generalizing this work, we consider the effect of visible matter and classify the types of rotation curves as we vary the fraction of the mass and extention of visible matter. We show that visible matter, in galaxies with flat rotation curves, has mass fraction $2\% \sim 10\%$ and it is confined within the distance fraction $10\% \sim 20\%$.Comment: 10 pages, 10 figures included, to appear in Phys. Rev. D50,p365

COPe-support - a multi-component digital intervention for family carers for people affected by psychosis: study protocol for a randomized controlled trial.

BACKGROUND: Psychosis often causes significant distress and impacts not only in the individuals, but also those close to them. Many relatives and friends ('carers') provide long-term support and need resources to assist them. We have co-produced a digital mental health intervention called COPe-support (Carers fOr People with Psychosis e-support) to provide carers with flexible access to high quality psychoeducation and interactive support from experts and peers. This study evaluates the effectiveness of COPe-support to promote mental wellbeing and caregiving experiences in carers. METHODS: This study is a single-blind, parallel arm, individually randomized controlled trial (RCT) comparing COPe-support, with attention control. Both groups continue to receive usual care. COPe-support provides interactive web-based psychoeducation on psychosis-related issues, wellbeing-promotion and network support through forums. The attention-control is a non-interactive online information resource pack. Carers living in England are eligible if they provide at least weekly support to a family member or close friend affected by psychosis, and use internet communication (including emails) daily. All trial procedures are run online, including collection of outcome measurements which participants will directly input into our secure platform. Following baseline assessment, a web-based randomization system will be used to allocate 360 carers to either arm. Participants have unlimited access to the allocated condition for 40 weeks. Data collection is at three time points (10, 20, and 40 weeks after randomization). Analyses will be conducted by trial statisticians blinded to allocation. The primary outcome is mental wellbeing measured by Warwick Edinburgh Mental Wellbeing Scale (WEMWBS), at 20 weeks. As well as an intention-to-treat analysis, a complier average causal effect (CACE) analysis will be conducted to estimate the intervention effect in participants who have accessed COPe-support content twice or more. The secondary objectives and analysis will examine other health and caregiving-related outcomes and explore mechanisms. In a process evaluation, we will interview 20% of the intervention arm participants regarding the acceptability of COPe-support. We will explore in detail participants' usage patterns. DISCUSSION: The results of this trial will provide valuable information about the effectiveness of COPe-support in promoting wellbeing and caregiving experiences in carers. TRIAL REGISTRATION: The RCT is registered with the Current Controlled Trials registration (ISRCTN 89563420, registration date: 02/03/2018)

The Dropping of In-Medium Hadron Mass in Holographic QCD

We study the baryon density dependence of the vector meson spectrum using the D4/D6 system together with the compact D4 baryon vertex. We find that the vector meson mass decreases almost linearly in density at low density for small quark mass, but saturates to a finite non-zero value for large density. We also compute the density dependence of the $\eta\prime$ mass and the $\eta\prime$ velocity. We find that in medium, our model is consistent with the GMOR relation up to a few times the normal nuclear density. We compare our hQCD predictions with predictions made based on hidden local gauge theory that is constructed to model QCD.Comment: 20 pages, 7 figure

Comments on Baryon Melting in Quark Gluon Plasma with Gluon Condensation

We consider a black hole solution with a non-trivial dilaton from IIB super gravity which is expected to describe a strongly coupled hot gauge plasma with non-vanishing gluon condensation present. We construct a rotating and moving baryon to probe the screening and phases of the plasma. Melting of the baryons in hot plasma in this background had been studied previously, however, we show that baryons melt much lower temperature than has been suggested previously.Comment: 3 figures, 12 page

The epigenetic regulator ATF7ip inhibits Il2 expression, regulating Th17 responses.

T helper 17 cells (Th17) are critical for fighting infections at mucosal surfaces; however, they have also been found to contribute to the pathogenesis of multiple autoimmune diseases and have been targeted therapeutically. Due to the role of Th17 cells in autoimmune pathogenesis, it is important to understand the factors that control Th17 development. Here we identify the activating transcription factor 7 interacting protein (ATF7ip) as a critical regulator of Th17 differentiation. Mice with T cell-specific deletion of Atf7ip have impaired Th17 differentiation secondary to the aberrant overproduction of IL-2 with T cell receptor (TCR) stimulation and are resistant to colitis in vivo. ChIP-seq studies identified ATF7ip as an inhibitor of Il2 gene expression through the deposition of the repressive histone mark H3K9me3 in the Il2-Il21 intergenic region. These results demonstrate a new epigenetic pathway by which IL-2 production is constrained, and this may open up new avenues for modulating its production